A Study to Assess the Safety, Efficacy and Immunogenicity of Leishmania Vaccine ChAd63-KH in PKDL
Clinical trial NCT03969134 · COMPLETED
Trial details
- NCT number
- NCT03969134
- Sponsor
- University of York
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-04-06
- Primary completion
- 2022-08-31
- Enrollment
- 86
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.